MRD in AML: the next step in fighting leukemia
Sysmex Inostics and Genomic Testing Cooperative Form Partnership to Accelerate Therapeutic Discovery a...
Sysmex Inostics industry-leading sensitivity for liquid biopsy
Sysmex Inostics Exhibits at American Association for Cancer Research Annual Meeting 2023 in Orlando
Liquid biopsy with Plasma-Safe-SeqS
With liquid biopsy, sensitivity matters
Sysmex Inostics Opens Cancer Research Excellence Program for Submissions
Exploring key mutations in colorectal cancer (CRC)
Importance of PI3K-AKT pathway-based biomarkers in breast cancer
The Prevalence and Outcomes of ESR1 Mutations in Breast Cancer
Liquid biopsies: from here to beyond
Sysmex Inostics Exhibits at Association of Molecular Pathology 2022 Annual Meeting & Expo in Phoe...